Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Exposure to Leishmania induces a humoral immune response that can be used as a marker of parasite exposure.
Herein, ELISA was used to screen sera from patients with Tegumentary Leishmaniasis (TL) against different L. infantum-chagasi-derived recombinant proteins (rHSP70, rH2A, rH2B, rH3, rH4 and rKMP11). Among the recombinant proteins, rHSP70 and rH2A showed the best reactivity against human sera obtained from endemic areas of TL. Receiver-Operator Characteristics (ROC) curve analysis was used to identify the effectiveness of these proteins for serodiagnosis of TL. ROC curves confirmed the superior performance of rHSP70 and rH2A, in comparison to the other tested recombinant proteins. Additionally, we evaluated the specificity of the response to rHSP70 and rH2A by testing sera obtained from patients with Chagas' disease, Tuberculosis, Leprosy or Systemic Lupus Erythematosus. In this case, rHSP70 displayed an increased ability to discriminate diseases, in comparison to SLA.
Our results raise possibility of using rHSP70 for the serodiagnosis of TL.
AuthorsAna Paula Souza, Manuel Soto, Jackson M L Costa, Viviane S Boaventura, Camila I de Oliveira, Juqueline R Cristal, Manoel Barral-Netto, Aldina Barral
JournalPloS one (PLoS One) Vol. 8 Issue 6 Pg. e66110 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23776617 (Publication Type: Evaluation Studies, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HSP70 Heat-Shock Proteins
  • Oligonucleotides
  • Protozoan Proteins
  • Recombinant Proteins
  • Enzyme-Linked Immunosorbent Assay
  • HSP70 Heat-Shock Proteins (metabolism)
  • Humans
  • Leishmania (genetics, immunology)
  • Leishmaniasis (blood, diagnosis)
  • Oligonucleotides (genetics)
  • Protozoan Proteins
  • ROC Curve
  • Recombinant Proteins
  • Serologic Tests (methods)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: